Offer - Urjas Oil for just ₹ 1 X
Tsart Trio 12.5 Tablet is a prescription medicine that is available as a Tablet. Tsart Trio 12.5 Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Tsart Trio 12.5 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
The side effects typically associated with Tsart Trio 12.5 Tablet include Back Pain, Loss of appetite, Gastric Irritation. Apart from the aforementioned side effects, Tsart Trio 12.5 Tablet can also lead to other problems, which have been listed below. These side effects of Tsart Trio 12.5 Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Tsart Trio 12.5 Tablet has a Mild effect for pregnant women and Mild effect on lactating mothers. Warnings related to Tsart Trio 12.5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Tsart Trio 12.5 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Low Blood Pressure (Hypotension), Angioedema, Hyperkalemia are examples of such conditions. Other contraindications of Tsart Trio 12.5 Tablet have been discussed in the sections ahead.
Drug reaction of Tsart Trio 12.5 Tablet with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Tsart Trio 12.5 Tablet is not safe while driving, and is not addiction.
Tsart Trio 12.5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Tsart Trio 12.5 Tablet safe for pregnant women?
Tsart Trio has little to no side effects in pregnant women.
Is the use of Tsart Trio 12.5 Tablet safe during breastfeeding?
Tsart Trio may have very limited harmful effects for breastfeeding women.
What is the effect of Tsart Trio 12.5 Tablet on the Kidneys?
Tsart Trio rarely affects the kidneys.
What is the effect of Tsart Trio 12.5 Tablet on the Liver?
Tsart Trio is rarely harmful for the liver.
What is the effect of Tsart Trio 12.5 Tablet on the Heart?
Tsart Trio may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Tsart Trio 12.5 Tablet unless your doctor advises you to do so -
Is this Tsart Trio 12.5 Tablet habit forming or addictive?
Tsart Trio 12.5 Tablet is not addictive in nature.
Interaction between Food and Tsart Trio 12.5 Tablet
Tsart Trio 12.5 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Tsart Trio 12.5 Tablet
Taking Tsart Trio 12.5 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448